Intestinal permeability and oxicity of second-line therapeutic agents in ovarian cancer.
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F08%3A00007574" target="_blank" >RIV/61989592:15110/08:00007574 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Intestinal permeability and oxicity of second-line therapeutic agents in ovarian cancer.
Original language description
We have read with interest the article by Li et al. in which the uthors desc use of intestinal permeability testing to demonstrate the protective effect of oral glutamine administration in breast carcinoma patients treated with the combination of cyclophospham epirubicin and 5-fluorouracil in the neoadjuvant setting.
Czech name
Změny intestinální permeability u karcinomu ovarii
Czech description
Popsány změny intestinální permeability u karcinomu ovarii
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
—
Continuities
S - Specificky vyzkum na vysokych skolach
Others
Publication year
2008
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Tumori
ISSN
0300-8916
e-ISSN
—
Volume of the periodical
94
Issue of the periodical within the volume
5
Country of publishing house
IT - ITALY
Number of pages
3
Pages from-to
—
UT code for WoS article
—
EID of the result in the Scopus database
—